Xynos Konstantinos's Form 4 filing
Replimune Group, Inc. (REPL) · filed Jun 10, 2024
- Accession no.
- 0001104659-24-070108
- Filed
- Jun 10, 2024
- Trade date
- Jun 7, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $119.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Xynos KonstantinosCIK 0001956241 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | Common Stock | SSaleDisposed | −15,881 | $7.50 | −$119,107.5 | 117,131 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.